Publishing research using ab38929? Please let us know so that we can cite the reference in this datasheet.

ab38929 has been referenced in 8 publications.

  • Ferreira DS  et al. Molecularly engineered self-assembling membranes for cell-mediated degradation. Adv Healthc Mater 4:602-12 (2015). PubMed: 25413155
  • Jiang Y  et al. Downregulation of SPARC expression inhibits the invasion of human trophoblast cells in vitro. PLoS One 8:e69079 (2013). WB . PubMed: 23935929
  • Barbaresi S  et al. Effects of human papillomavirus type 16 E5 deletion mutants on epithelial morphology: functional characterization of each transmembrane domain. J Gen Virol 91:521-30 (2010). IHC-P ; Human . PubMed: 19812262
  • Keld R  et al. The ERK MAP kinase-PEA3/ETV4-MMP-1 axis is operative in oesophageal adenocarcinoma. Mol Cancer 9:313 (2010). WB ; Human . PubMed: 21143918
  • Doehn U  et al. RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells. Mol Cell 35:511-22 (2009). WB ; Human, Dog . PubMed: 19716794
  • Stojic J  et al. Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas. Neurosci Res 60:40-9 (2008). PubMed: 17980449
  • Yuan ZQ  et al. Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts. J Virol 82:6481-91 (2008). ICC/IF ; Horse . PubMed: 18434409
  • Ishikawa A  et al. Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia. Neurosci Res 59:406-12 (2007). IHC-P ; Human . PubMed: 17889387

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"